INVESTINGJim Cramer: Why Doesn’t Apple Just Go Ahead and Buy Netflix?By Jim CramerMay 12, 2015 6:00 AM EDT
MERGERS AND ACQUISITIONSTeva, Actavis, Other Generic Drugmakers May Be on Acquisition TrailBy Laura CooperApr 16, 2015 10:04 AM EDT
MERGERS AND ACQUISITIONSTeva, Actavis, Other Giants Set to Battle for Generics SpaceBy Laura CooperApr 15, 2015 11:30 AM EDT
OPINIONWhy Endo International Can Deliver Solid Rewards With Minimal RiskBy Richard SaintvilusSep 2, 2014 2:31 PM EDT
INVESTINGLove the Stocks Everyone Hates: 5 Short-Squeeze Stocks Ready to PopBy Jonas ElmerrajiJun 25, 2014 10:34 AM EDT
MARKETSTrade-Ideas: Forest Laboratories (FRX) Is Today's Momo Momentum StockBy Daniel MirkinJun 23, 2014 10:01 AM EDT
MARKETSFRX, AZN And ACT, 3 Health Care Stocks Pushing The Sector LowerBy Mike HensonMay 28, 2014 1:03 PM EDT
MARKETSWill This Price Target Increase Help Forest Laboratory (FRX) Stock Today?By Lindsay IngramMay 19, 2014 9:18 AM EDT
MARKETSForest Laboratories Inc (FRX): Today's Featured Drugs LaggardBy TheStreet WireMay 6, 2014 5:01 PM EDT
OPINIONHealth Care Stocks Still Healthy Despite Higher Hedging CostsBy Alessandra Rose Miguel-DescalsoMay 2, 2014 6:30 AM EDT
MARKETSU.S. Stocks Mount Midday Turnaround to Close Higher, Bank of America PlungesBy Jane SearleApr 28, 2014 4:19 PM EDT
MERGERS AND ACQUISITIONSForest Laboratories Inks $1.4B Deal for FuriexBy Lou WhitemanApr 28, 2014 11:40 AM EDT
MARKETSToday's Unusual Social Activity Stock: Forest Laboratories (FRX)By Scott OlsonApr 28, 2014 10:33 AM EDT
MERGERS AND ACQUISITIONSMeda Rejects New Mylan Takeover ProposalBy Andrew BulkeleyApr 28, 2014 9:16 AM EDT
MARKETSForest Laboratories Inc (FRX): Today's Featured Drugs LaggardBy TheStreet WireApr 25, 2014 5:01 PM EDT
MARKETSMYL, FRX And ACT, 3 Drugs Stocks Pushing The Industry LowerBy Raina SharmaApr 17, 2014 1:03 PM EDT
MARKETSForest Laboratories Inc. (FRX): Today's Featured Health Care LaggardBy TheStreet WireMar 26, 2014 5:01 PM EDT
